FL-501

N/A

Report date: 2025/05/08 10:52:47

Base Information

Drug NameFL-501
Drug Alias NameFL-501
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionGrowth/differentiation factor 15 inhibitors
TargetsGrowth/differentiation factor 15
Therapy Area/IndicationsCachexiaProstatic NeoplasmsPancreatic Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFlame Biosciences IncAdimab LLC
China Registration ClassN/A

Develop Information

Active CompaniesAdimab LLCLeap Therapeutics IncFlame Biosciences Inc
Inactive CompaniesN/A
Active IndicationsCachexiaProstatic NeoplasmsPancreatic Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A